Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Vivani Medical Inc (VANI)

Vivani Medical Inc (VANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 69,897
  • Shares Outstanding, K 59,235
  • Annual Sales, $ 0 K
  • Annual Income, $ -25,650 K
  • EBIT $ -24 M
  • EBITDA $ -24 M
  • 60-Month Beta 3.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.56

Options Overview Details

View History
  • Implied Volatility 147.38% ( +1.20%)
  • Historical Volatility 57.86%
  • IV Percentile 47%
  • IV Rank 15.81%
  • IV High 836.65% on 01/24/24
  • IV Low 17.92% on 06/06/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 39
  • Volume Avg (30-Day) 41
  • Put/Call OI Ratio 0.69
  • Today's Open Interest 2,410
  • Open Int (30-Day) 2,204

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.10
  • Number of Estimates 1
  • High Estimate -0.10
  • Low Estimate -0.10
  • Prior Year -0.12
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1400 +3.51%
on 12/20/24
1.5000 -21.33%
on 11/27/24
-0.1100 (-8.53%)
since 11/20/24
3-Month
1.1000 +7.27%
on 10/10/24
1.5000 -21.33%
on 11/27/24
-0.0500 (-4.07%)
since 09/20/24
52-Week
0.8400 +40.48%
on 12/21/23
7.8000 -84.87%
on 02/28/24
+0.3032 (+34.58%)
since 12/20/23

Most Recent Stories

More News
Vivani Medical: Q3 Earnings Snapshot

Vivani Medical: Q3 Earnings Snapshot

VANI : 1.1800 (unch)
Vivani Medical: Q2 Earnings Snapshot

Vivani Medical: Q2 Earnings Snapshot

VANI : 1.1800 (unch)
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study

Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an emerging biopharmaceutical company which develops miniaturized, subdermal implants today announced that the Company received...

VANI : 1.1800 (unch)
Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment...

VANI : 1.1800 (unch)
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division

Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, today announced the...

VANI : 1.1800 (unch)
Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates

Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants including lead asset NPM-119 for the treatment of patients...

VANI : 1.1800 (unch)
Vivani Medical to Present at the ThinkEquity Investor Conference

Vivani Medical, Inc. (NASDAQ: VANI) (the “Company” or “Vivani”), an innovative, clinical-stage biopharmaceutical company that develops novel, long-term therapeutic implants, announced today that...

VANI : 1.1800 (unch)
Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)

Vivani Medical, Inc., formerly Second Sight Medical, Inc., (NASDAQ: VANI) (the “Company” or “Vivani”) announced that trading of the Company’s common stock on The Nasdaq Capital Market under the...

EYES : 4.14 (-5.05%)
VANI : 1.1800 (unch)

Business Summary

Vivani Medical Inc. is the combination of Nano Precision Medical, Inc. and Second Sight Medical Products, Inc. The Company leverages proprietary technologies to develop and commercialize drug and device implants that treat patients with chronic diseases. Vivani Medical Inc., formerly known as Second...

See More

Key Turning Points

3rd Resistance Point 1.3000
2nd Resistance Point 1.2600
1st Resistance Point 1.2200
Last Price 1.1800
1st Support Level 1.1400
2nd Support Level 1.1000
3rd Support Level 1.0600

See More

52-Week High 7.8000
Fibonacci 61.8% 5.1413
Fibonacci 50% 4.3200
Fibonacci 38.2% 3.4987
Last Price 1.1800
52-Week Low 0.8400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar